These observations suggest that ILC2 blocked AAA growth directly by acting on lesional SMCs and indirectly by acting on SMCs, ECs, and lesion inflammatory cells via the IL5 and EOS mechanisms. The gene discussed is IL5; the disease is triple-A syndrome.